BrainsWay Ltd has a consensus price target of $11.5 based on the ratings of 5 analysts. The high is $15 issued by HC Wainwright & Co. on June 5, 2024. The low is $5 issued by Northland Capital Markets on November 17, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co. on June 5, 2024, May 9, 2024, and May 9, 2024, respectively. With an average price target of $13.67 between HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co., there's an implied 104.59% upside for BrainsWay Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/05/2024 | Buy Now | 124.55% | HC Wainwright & Co. | Raghuram Selvaraju | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 64.67% | Oppenheimer | Steven Lichtman | $10 → $11 | Maintains | Outperform | Get Alert |
05/09/2024 | Buy Now | 124.55% | HC Wainwright & Co. | Raghuram Selvaraju | $13 → $15 | Maintains | Buy | Get Alert |
03/11/2024 | Buy Now | 94.61% | HC Wainwright & Co. | Raghuram Selvaraju | $12 → $13 | Maintains | Buy | Get Alert |
11/16/2023 | Buy Now | -10.18% | Oppenheimer | Steven Lichtman | $5.5 → $6 | Maintains | Outperform | Get Alert |
11/16/2023 | Buy Now | — | Raymond James | Jayson Bedford | — | Downgrade | Outperform → Market Perform | Get Alert |
09/22/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
09/06/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
08/24/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
08/21/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
06/05/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
05/18/2023 | Buy Now | -25.15% | Oppenheimer | Steven Lichtman | → $5 | Reiterates | Outperform → Outperform | Get Alert |
05/18/2023 | Buy Now | -55.09% | Raymond James | Jayson Bedford | $3.75 → $3 | Maintains | Outperform | Get Alert |
04/13/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Raghuram Selvaraju | $13 → $12 | Maintains | Buy | Get Alert |
02/01/2023 | Buy Now | 94.61% | HC Wainwright & Co. | Raghuram Selvaraju | → $13 | Reiterates | → Buy | Get Alert |
12/12/2022 | Buy Now | 94.61% | HC Wainwright & Co. | Raghuram Selvaraju | $16 → $13 | Maintains | Buy | Get Alert |
11/21/2022 | Buy Now | -43.86% | Raymond James | Jayson Bedford | $8 → $3.75 | Maintains | Outperform | Get Alert |
11/17/2022 | Buy Now | -25.15% | Northland Capital Markets | Carl Byrnes | $15 → $5 | Maintains | Outperform | Get Alert |
08/22/2022 | Buy Now | 139.52% | HC Wainwright & Co. | Raghuram Selvaraju | $15 → $16 | Maintains | Buy | Get Alert |
08/11/2022 | Buy Now | 19.76% | Raymond James | Jayson Bedford | $10 → $8 | Maintains | Outperform | Get Alert |
05/12/2022 | Buy Now | 49.7% | Raymond James | Jayson Bedford | $12 → $10 | Maintains | Outperform | Get Alert |
03/03/2022 | Buy Now | 124.55% | Loop Capital | Jason Wittes | → $15 | Initiates | → Buy | Get Alert |
11/29/2021 | Buy Now | 124.55% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
08/12/2021 | Buy Now | 109.58% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
07/19/2021 | Buy Now | 154.49% | HC Wainwright & Co. | Raghuram Selvaraju | — | Initiates | → Buy | Get Alert |
The latest price target for BrainsWay (NASDAQ:BWAY) was reported by HC Wainwright & Co. on June 5, 2024. The analyst firm set a price target for $15.00 expecting BWAY to rise to within 12 months (a possible 120.59% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for BrainsWay (NASDAQ:BWAY) was provided by HC Wainwright & Co., and BrainsWay reiterated their buy rating.
There is no last upgrade for BrainsWay
The last downgrade for BrainsWay Ltd happened on November 16, 2023 when Raymond James changed their price target from N/A to N/A for BrainsWay Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrainsWay, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrainsWay was filed on June 5, 2024 so you should expect the next rating to be made available sometime around June 5, 2025.
While ratings are subjective and will change, the latest BrainsWay (BWAY) rating was a reiterated with a price target of $15.00 to $15.00. The current price BrainsWay (BWAY) is trading at is $6.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.